J025 Establishing feasibility for cell replacement therapy - outcomes from the trident (trial designs for delivery of novel therapies for neurodegeneration) trial [Abstract]

Drew, Cheney ORCID: https://orcid.org/0000-0002-4397-6252, Smallman, Kim ORCID: https://orcid.org/0000-0002-9283-8120, Pallmann, Philip ORCID: https://orcid.org/0000-0001-8274-9696, Burrell, Astrid, Brookes-Howell, Lucy ORCID: https://orcid.org/0000-0002-8263-7130, Busse, Monica ORCID: https://orcid.org/0000-0002-5331-5909, Gray, William P. ORCID: https://orcid.org/0000-0001-7595-8887 and Rosser, Anne ORCID: https://orcid.org/0000-0002-4716-4753 2024. J025 Establishing feasibility for cell replacement therapy - outcomes from the trident (trial designs for delivery of novel therapies for neurodegeneration) trial [Abstract]. Journal of Neurology, Neurosurgery and Psychiatry 95 (S1) , A170. 10.1136/jnnp-2024-EHDN.346

Full text not available from this repository.

Item Type:	Short Communication
Date Type:	Published Online
Status:	Published
Schools:	Schools > Medicine Research Institutes & Centres > Centre for Trials Research (CNTRR)
Publisher:	BMJ Publishing Group
ISSN:	0022-3050
Funders:	Health Care Research Wales
Projects:	TRIDENT
Last Modified:	20 Jan 2026 15:29
URI:	https://orca.cardiff.ac.uk/id/eprint/184045

Actions (repository staff only)

Edit Item